Zydus gets USFDA tentative nod for Empagliflozin Tablets Medical Dialogues Bureau11 April 2020 12:17 PM ISTAhmedabad: Zydus Cadila has received tentative approval from the USFDA to market Empagliflozin Tablets, in the strengths of 10 mg and 25 mg (US RLD:...
Zydus gets USFDA nod for Lamotrigine Extended-Release Tablets for seizures Medical Dialogues Bureau3 April 2020 1:32 PM ISTAhmedabad: Zydus Cadila has received final approval from the USFDA to market Lamotrigine Extended-Release Tablets USP in the strengths of 25 mg, 50...
Zydus gets USFDA tentative nod for Carbidopa, Levodopa Extended-Release Capsules Medical Dialogues Bureau31 March 2020 1:30 PM ISTAhmedabad: Zydus Cadila has received tentative approval from the USFDA to market Carbidopa and Levodopa Extended-Release Capsules in the strengths of...
Cadila Healthcare BOD approves transfer of Animal Healthcare Business to Zydus Animal Health and Investments Limited Medical Dialogues Bureau15 March 2020 9:00 AM ISTNew Delhi: Cadila Healthcare Ltd. has recently announced that the Board of Directors at its meeting, has approved the transfer of Animal Healthcare...
Zydus, XOMA enter into licensing agreement for IL-2-Based Immuno-Oncology Therapy Medical Dialogues Bureau11 March 2020 9:00 AM ISTAhmedabad, Emeryville: Zydus Cadila and XOMA Corporation have announced they have entered into a licensing agreement to advance an IL-2-based...
Zydus gets DCGI nod for Phase I clinical trial of ZYBK2b to treat Rheumatoid Arthritis Medical Dialogues Bureau4 March 2020 10:34 AM ISTZYBK2 has been specifically designed to inhibit HLA-DRB1 Shared Epitope (SE) that determines the susceptibility of a person to develop rheumatoid...
Prices of Paracetamol surge by 40pc as coronavirus shuts China Farhat Nasim18 Feb 2020 1:21 PM ISTPrices of paracetamol, the most commonly used analgesic, have jumped by 40% in India, while the cost of azithromycin, an antibiotic used for treating...
Zydus Cadila announces research Program to develop Coronavirus Vaccine Medical Dialogues Bureau17 Feb 2020 2:56 PM ISTZydus has two state-of-the-art R&D Centres, one located in Catania, Italy and the other in Ahmedabad, in the western part of India
Zydus Cadila gets USFDA nod for bowel disease drug Mesalamine suppositories Farhat Nasim13 Feb 2020 1:04 PM IST"Zydus Cadila has received the final approval from the USFDA to market Mesalamine Suppositories for rectal use...1000 mg," the drug firm said in a...
Zydus Cadila gets USFDA nod for Fluocinonide cream to treat skin conditions Medical Dialogues Bureau12 Feb 2020 12:51 PM ISTFluocinonide cream USP, 0.1 per cent, approved by USFDA is indicated to treat a variety of skin conditions such as psoriasis, eczema, dermatitis,...
Cadila Healthcare Ahmedabad facility clears USFDA inspection Farhat Nasim5 Feb 2020 9:15 AM IST United States Food and Drug Administration (USFDA) inspected the manufacturing facility of Alidac Pharmaceuticals, the company's wholly-owned...
Zydus Cadila gets DGCI nod for diabetes drug Saroglitazar Magnesium Farhat Nasim4 Feb 2020 10:30 AM IST"Zydus Cadila has received the approval from the Drug Controller General of India (DCGI) for use of Saroglitazar Mg in the treatment of type II...
